Volume 4, Number 2—June 1998
Synopsis
Haemophilus influenzae Invasive Disease in the United States, 1994–1995: Near Disappearance of a Vaccine-Preventable Childhood Disease
Table 5
Children aged < 4 years with invasive Hib disease,a by number of Hib vaccine doses received and age group, United States, 1994 – 1995
| No. of children receiving vaccineb |
Vaccination status unknown | Total | ||||||
|---|---|---|---|---|---|---|---|---|
| Age (mos.) | Rec.c | 0 | 1 | 2 | 3 | 4 | ||
| 0-1 | 0 | 15 | 2 | 17 | ||||
| 2-3 | 1 | 17 | 12 | 9 | 38 | |||
| 4-5 | 2 | 7 | 13 | 2 | 8 | 30 | ||
| 6-11 | 3 | 13 | 8 | 11 | 6 | 7 | 45 | |
| 12-18 | 4 | 5 | 1 | 2 | 7 | 2 | 0 | 17 |
| 19-59 | 4 | 11 | 5 | 1 | 7 | 4 | 6 | 34 |
| Total | 4 | 68 | 39 | 16 | 20 | 6 | 32 | 181 |
aExcludes three children aged <1 year but missing age in months; vaccination status was unknown for two of the children, and one child was unvaccinated.
bFive children completed a primary series with 2 doses of PedvaxHIB (at ages 7, 11, 13, 14, and 43 months); two children completed a primary series with 1 dose at >15 months of age.
cCumulative recommended doses for PRP-T and HbOC vaccines.
Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.